title: Solution NMR of a 463-residue phosphohexomutase: domain 4 mobility, substates, and phosphoryl transfer defect.
abstract: Phosphomannomutase/phosphoglucomutase contributes to the infectivity of Pseudomonas aeruginosa, retains and reorients its intermediate by 180°, and rotates domain 4 to close the deep catalytic cleft. Nuclear magnetic resonance (NMR) spectra of the backbone of wild-type and S108C-inactivated enzymes were assigned to at least 90%. (13)C secondary chemical shifts report excellent agreement of solution and crystallographic structure over the 14 α-helices, C-capping motifs, and 20 of the 22 β-strands. Major and minor NMR peaks implicate substates affecting 28% of assigned residues. These can be attributed to the phosphorylation state and possibly to conformational interconversions. The S108C substitution of the phosphoryl donor and acceptor slowed transformation of the glucose 1-phosphate substrate by impairing k(cat). Addition of the glucose 1,6-bisphosphate intermediate accelerated this reaction by 2-3 orders of magnitude, somewhat bypassing the defect and apparently relieving substrate inhibition. The S108C mutation perturbs the NMR spectra and electron density map around the catalytic cleft while preserving the secondary structure in solution. Diminished peak heights and faster (15)N relaxation suggest line broadening and millisecond fluctuations within four loops that can contact phosphosugars. (15)N NMR relaxation and peak heights suggest that domain 4 reorients slightly faster in solution than domains 1-3, and with a different principal axis of diffusion. This adds to the crystallographic evidence of domain 4 rotations in the enzyme, which were previously suggested to couple to reorientation of the intermediate, substrate binding, and product release.
authors.affiliation: Biochemistry Department, University of Missouri, Columbia, Missouri 65211, United States.
authors.forename: Akella V S
authors.initials: AV
authors.lastname: Sarma
authors.forename: Asokan
authors.initials: A
authors.lastname: Anbanandam
authors.forename: Allek
authors.initials: A
authors.lastname: Kelm
authors.forename: Ritcha
authors.initials: R
authors.lastname: Mehra-Chaudhary
authors.forename: Yirui
authors.initials: Y
authors.lastname: Wei
authors.forename: Peiwu
authors.initials: P
authors.lastname: Qin
authors.forename: Yingying
authors.initials: Y
authors.lastname: Lee
authors.forename: Mark V
authors.initials: MV
authors.lastname: Berjanskii
authors.forename: Jacob A
authors.initials: JA
authors.lastname: Mick
authors.forename: Lesa J
authors.initials: LJ
authors.lastname: Beamer
authors.forename: Steven R
authors.initials: SR
authors.lastname: Van Doren
mesh_terms: D020134:Catalytic Domain / Q000235:genetics; D018360:Crystallography, X-Ray; D019906:Nuclear Magnetic Resonance, Biomolecular; D010733:Phosphoglucomutase / Q000737:chemistry / Q000235:genetics; D010766:Phosphorylation / Q000235:genetics; D017875:Phosphotransferases (Phosphomutases) / Q000737:chemistry* / Q000235:genetics* / Q000378:metabolism; D011485:Protein Binding / Q000235:genetics; D021381:Protein Transport / Q000235:genetics; D011550:Pseudomonas aeruginosa / Q000201:enzymology; D013379:Substrate Specificity / Q000235:genetics
chemical_list: D017875:Phosphotransferases (Phosphomutases); D010733:Phosphoglucomutase; C052799:phosphomannomutase